首页> 外文期刊>Materials science & engineering, C. Materials for Biogical applications >Y-shaped methoxy poly (ethylene glycol)-block-poly (epsilon-caprolactone)-based micelles for skin delivery of ketoconazole: in vitro study and in vivo evaluation
【24h】

Y-shaped methoxy poly (ethylene glycol)-block-poly (epsilon-caprolactone)-based micelles for skin delivery of ketoconazole: in vitro study and in vivo evaluation

机译:Y形甲氧基聚(乙二醇) - Block-poly(epsilon-己内酯)基于酮康唑皮肤递送的基于胶束:体外研究和体内评价

获取原文
获取原文并翻译 | 示例
           

摘要

Ketoconazole is a hydrophobic broad-spectrum antifungal agent for skin infection therapy. In order to develop topical formulation of ketoconazole for improving its selective skin deposition and water-solubility, ketoconazole-loaded Y-shaped monomethoxy poly(ethylene glycol)-block-poly(epsilon-caprolactone) micelles were prepared through thin-film hydration method with high entrapment efficiency (96.1 +/- 0.76%) and small particle (about 58.66 nm). The drug-loaded micelles showed comparative in vitro antimicrobial activity with KET cream. In ex in vivo skin deposition and permeation study, ketoconazole-loaded micelles provided skin accumulation higher than marketed ketoconazole cream without obvious permeation in the whole period. Fluorescence microscopy study and histopathological study demonstrated the copolymeric micelles' penetrating into skin in depth due to its capability of weakening the barrier function of stratum corneum. In vivo skin deposition parameters further confirmed high skin deposition of drug-loaded micelles (AUC((0-t)) = 396.16 mu g.h/cm(2)) over marketed ketoconazole cream (AUC((0-t)) = 250.03 mu g.h/cm(2)). Meanwhile, in vivo pharmacokinetic parameters proved that ketoconazole-loaded micelles reduced ketoconazole's distribution in blood in comparison with the cream (AUC((0-t)) = 93,028.00 mu g.h/L vs AUC((0-t)) = 151,714.00 mu g.h/L), meaning lower possibility of its systemic unwanted effects in the skin fungal infection treatment. The results suggested that the copolymeric micelles can be adopted for specific delivering ketoconazole into skin for fungal infection cure. (C) 2017 Elsevier B.V. All rights reserved.
机译:酮康唑是一种用于皮肤感染治疗的疏水性广谱抗真菌剂。为了通过薄膜水合方法制备酮康唑负载的Y形单甲氧基聚(乙二醇)二甲氧基聚(乙二醇)二甲氧基聚(乙二醇)二甲氧基聚(乙二醇) - 乙二醇溶解 - 聚(epsilon-己内酯)胶束进行制备高血管效率(96.1 +/- 0.76%)和小颗粒(约58.66nm)。药物负载的胶束显示与乙醛霜的比较体外抗微生物活性。在体内皮肤沉积和渗透性研究中,酮康唑加载的胶束提供了高于市场上的皮肤积累,整个时期没有明显渗透的酮康唑霜。荧光显微镜研究和组织病理学研究表明,由于其削弱了角质层的阻挡函数,因此证明了共聚物胶束深入渗透到皮肤中。在体内皮肤沉积参数中进一步证实了药物胶束的高皮肤沉积(AUC((0-T))=396.16μg/ cm(2))上市酮烷唑霜(AUC((0-T))= 250.03亩gh / cm(2))。同时,体内药代动力学参数证明,与奶油(AUC((0-T))= 93,028.00 mu GH / L VS AUC((0-T))= 151,714.00亩GH / l),意味着其在皮肤真菌感染治疗中其系统性不良影响的可能性降低。结果表明,共聚物胶束可以用于特异性将酮康唑递送到皮肤中,用于真菌感染治疗。 (c)2017 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号